🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

1/n Hyponatremia in cirrhosis rounds: case 1: ESLD 2/2 ETOH. Admitted at OUH 2/2 abd distension/lethargy w/sNa 133. Kept on spirono + furosem + lactulose. Gradual ⬇️in sNa in 10 days. Transferred 4 ⬆️level of care. Arrives with sNa 125, sCr 0.8. Alert, jaundice, ascites, no edema

Juan Carlos Q Velez Channel Your Enthusiasm: The Burton Rose BookClub This is amazing, and timely - I very recently had reason to wonder how all those nonosmotic ADH release types worked.

🖼️ #kidneylove #kidneyart #neon #neonart #eighties

Irene Toh Juan Carlos Q Velez And remember, the diagnosis predicts how responsive people are to ADH antagonists; Heart failure, fairly resistant. SIAD highly sensitive.

Summary of the H3Africa APOL1 study on our blog: is-gd.org/en/news-from-i…

Calcium phosphate “plates” or “continents”, 4x objective, SM stain, bright field, polarized light; acute hyperphosphatemia, AKI, ATN, DKA, shock. #UrinarySediment #UrineMicroscopy Ochsner Nephrology Carolina Glz Fuentes #crystalluria

Holy moly, glass shards more like!

El iSGLT2 canagliflozina a dosis de 100 o 300mg en personas en hemodiálisis, tuvo prácticamente la misma farmacocinética, al compararse a sujetos sanos; es igual de segura y no se elimina en las sesiones de hemodiálisis #ISNyoung Kidney Int Rep 2024 doi.org/10.1016/j.ekir…

Con lesión renal aguda y diálisis en cirrosis, el 59% murió a 3 meses; el riesgo ↑62% si hubo vasopresores y ↑2.6 veces si ameritó TRRC, sobresale que no hace diferencia en mortalidad si la etiología fue hepatorrenal PostHoc HRS-HARMONY Kidney360 2024 10.34067/KID.0000000589

🔬 Dr. Dana Rizk reported in the NEJM that using iptacopan to treat patients with IgA nephropathy—a frequent cause of kidney failure—led to a significant reduction in proteinuria compared to the placebo group. 👏 Kudos to Dr. Rizk and her team! @UABNRTC

Trying this platform these days. See you there. bsky.app/profile/juanca…

Addition of a Loop Diuretic to Norepinephrine During Treatment of Hepatorenal Syndrome Type 1 KIReports #openaccess ow.ly/lXak50U9E4e

Juan Carlos Q Velez & colleagues , thank you . Very informative

S.E.N. Nefrología TheChemistry ☣️🧬 Francisco Naranjo Juan Carlos Q Velez S.E.N. Nefrología José A. T. Poloni Jay R. Seltzer American Society of Nephrology Citem Sílvia Gràcia-Garcia Alejandro Maldonado Riñón Acido

Hanging out in this platform these days: bsky.social/about as [email protected] and I’m liking it. Hope to see most members of our #NephCommunity over there

Addition of a #LoopDiuretic to #Norepinephrine During Treatment of #Hepatorenal Syndrome Type 1 #VisualAbstract by Dr Priti MD,FASN🇮🇳 (प्रिति) kireports.org/article/S2468-… Juan Carlos Q Velez

Con síndrome hepatorrenal, en los que alcanzaron la meta de ↑ presión arterial media >15mmHg, combinar furosemida y norepinefrina se asoció a ↑orina de 250ml a 2,500ml, el 73% de ellos mantuvo o mejoró su creatinina Juan Carlos Q Velez Kidney Int Rep 2024 doi.org/10.1016/j.ekir…

Adding diuretics in HRS is not so bad after all ! KIReports Juan Carlos Q Velez #NephTwitter #MedTwitter #HRS

Undoubtedly the highlight of #ApexPathshala this year #teamRodbyTopf Not to forget the very memorable electrolyte tasting session by Joel M. Topf, MD FACP & Juan Carlos Q Velez last year! Swapnil Hiremath @hswapnil.medsky.social Dr Jatin Kothari MD DM FISOT FISN FICN FASN FRCP Rajesh Kumar Prakash Shirodkar

En nefropatía membranosa antiPLA2R de moderado riesgo, la combinación de Rituximab, Ciclofosfamida y Prednisona (como en Vasculitis ANCA), rápidamente ↓98% los valores de antiPLA2R y el 73% alcanzo remisión completa #ISNyoung Kidney Int Rep 2024 doi.org/10.1016/j.ekir…